COVID-19相关嗅觉丧失与病毒感染后嗅觉功能障碍的嗅觉MRI、DTI及fMRI对比研究
回顾性比较31例持续性COVID-19相关嗅觉障碍与97例感染后嗅觉障碍患者的嗅球MRI、DTI及嗅觉fMRI表现。COVID-19组嗅球体积显著高于感染后组,嗅神经聚集率和眶额区、内嗅区QA值更高,三叉神经感觉活动更强;嗅球形态变形和信号增高率两组无显著差异。作者认为嗅球损伤可能在持续性COVID-19相关嗅觉丧失中起核心作用。
要点
- COVID-19相关嗅觉丧失患者嗅球体积显著高于感染后嗅觉障碍患者。
- COVID-19组嗅神经聚集率及眶额区、内嗅区QA值显著高于感染后组。
- 两组嗅球形态变形和信号增高率无显著差异,COVID-19组三叉神经感觉活动更强。
核心结论
- 嗅球损伤可能在持续性COVID-19相关嗅觉丧失中起核心作用;尽管COVID-19相关嗅觉丧失存在嗅球体积减小和嗅觉区域白质束完整性下降,但程度不如其他感染后嗅觉障碍明显;COVID-19相关嗅觉障碍的三叉神经感觉活动更强,这些发现可能反映COVID-19相关嗅觉障碍的中枢嗅觉系统保存较好。
研究设计与样本
- 回顾性评估31例持续性COVID-19相关嗅觉障碍患者和97例感染后嗅觉障碍患者的嗅球MRI、DTI及嗅觉fMRI表现。
关键影像表现/征象
- COVID-19相关嗅觉障碍组嗅球体积显著高于感染后嗅觉障碍组。
- 嗅球形态变形在COVID-19相关嗅觉障碍组占58.1%、感染后嗅觉障碍组占63.9%,两组无显著差异。
- 嗅球信号增高在COVID-19相关嗅觉障碍组占51.6%、感染后嗅觉障碍组占46.4%,两组无显著差异。
- COVID-19相关嗅觉障碍组嗅神经聚集率显著高于感染后嗅觉障碍组。
- 眶额区和内嗅区QA值在COVID-19相关嗅觉障碍组显著高于感染后嗅觉障碍组。
诊断标准与关键数值
- COVID-19相关嗅觉障碍组全部为嗅觉丧失,感染后嗅觉障碍组18.6%为嗅觉减退、其余81.4%为嗅觉丧失。
- 嗅觉障碍起病至影像检查的平均间隔:COVID-19相关嗅觉障碍组1.5个月,感染后嗅觉障碍组6个月。
- 眶额区和内嗅区活动缺失在COVID-19相关嗅觉障碍组与感染后嗅觉障碍组之间无统计学显著差异。
临床应用与阅片要点
- 阅片时可关注嗅球体积、嗅球形态和信号、嗅神经聚集、眶额区和内嗅区QA值及三叉神经感觉活动等指标。
- 报告时应结合嗅觉障碍起病至影像检查的间隔,COVID-19相关嗅觉障碍组平均1.5个月、感染后嗅觉障碍组6个月。
- 原文结论指出嗅球损伤可能在持续性COVID-19相关嗅觉丧失中起核心作用,影像表现需结合临床嗅觉障碍病程解读。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVE: To evaluate how COVID-19 anosmia imaging findings resembled and differed from postinfectious olfactory dysfunction (OD).
MATERIAL AND METHODS: A total of 31 patients presenting with persistent COVID-19 related OD and 97 patients with post-infectious OD were included. Olfactory bulb MRI, DTI and olfactory fMRI findings in both groups were retrospectively assessed.
RESULTS: All COVID-19 related OD cases were anosmic, 18.6% of post-infectious OD patients were hyposmic and remaining 81.4% were anosmic. Mean interval between onset of OD and imaging was 1.5 months for COVID-19 related OD and 6 months for post-infectious OD. Olfactory bulb volumes were significantly higher in COVID-19 related OD than post-infectious OD. Deformed bulb morphology and increased olfactory bulb signal intensity was seen in 58.1% and 51.6% with COVID-19 related OD; and 63.9% - 46.4% with post-infectious OD; without significant difference. Significantly higher rate of olfactory nerve clumping and higher QA values at orbitofrontal and entorhinal regions were observed in COVID-19 related OD than post-infectious OD. Absence of orbitofrontal and entorhinal activity showed no statistically significant difference between COVID-19 related OD and post-infectious OD, however trigeminosensory activity was more robust in COVID-19 related OD cases.
CONCLUSION: Olfactory bulb damage may play a central role in persistent COVID-19 related anosmia. Though there is decreased olfactory bulb volume and decreased white matter tract integrity of olfactory regions in COVID-19 related anosmia, this is not as pronounced as in other post-infectious OD. Trigeminosensory activity was more robust in COVID-19 related OD. These findings may reflect better preserved central olfactory system in COVID-19 related OD compared to COVID-19 related OD.
引用
- Yildirim D, Kandemirli SG, Tekcan Sanli DE, et al. A Comparative Olfactory MRI, DTI and fMRI Study of COVID-19 Related Anosmia and Post Viral Olfactory Dysfunction. Acad Radiol. 2021. PMID: 34810059. doi:10.1016/j.acra.2021.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。